English

EXAGEN INC.

EDGAR

XGN Quarterly report (10-Q) · filed 2026-08-04

Annual consolidated revenue for 2025: about USD 66.58M, using the latest reported figures. The previous period, 2024, was about USD 55.64M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

19.9 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 19941000 USD Source

Operating margin

-8.64%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -1722000 USD Source
Revenue: 19941000 USD Source

Operating cash flow

3.99 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -6429000 USD Source
Operating Cash Flow: -10417000 USD Source

Free cash flow

3.45 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -6429000 USD Source
Operating Cash Flow: -10417000 USD Source
Capital Expenditure: 771000 USD Source
Capital Expenditure: 228000 USD Source

Cash and cash equivalents: 24.6 million USD 2026-06-30 Source
Exact value

24588000 USD
Long-term debt including current maturities: 22.8 million USD 2026-06-30 Source
Exact value

22839000 USD
Shares outstanding: 24.2 million shares 2026-06-30 Source
Exact value

24193101 shares

Reported share-count change

9.97% · 2.19 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

21998739 shares · 2025-06-30· Source
24193101 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

71.1 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 17244000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 66575000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 49944000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 17306000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 19941000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-18.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -7087000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -19951000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -15278000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -3967000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -3196000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-6.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -10612000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -13556000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -13625000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -10612000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -10417000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -6429000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -10417000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

1.09 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Capital expenditure: 597000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 322000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 641000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 597000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 228000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 771000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 228000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-7.59 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -10612000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -13556000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -13625000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -10612000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -10417000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -6429000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -10417000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 597000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 322000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 641000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 597000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 228000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 771000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 228000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-04.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 7 of 11 periods available· newest 2025-12-31
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.7%

Prior period

USD 55.64 million

2024-01-01 – 2024-12-31
Current period

USD 66.58 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

66575000 − 55641000 = 10934000 USD

55641000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
66575000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Year-over-year change in Revenue: 10934000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 66575000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1304656 Filing: 000127473726000009 Input fundies:Revenue: 55641000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1305627 Filing: 000127473726000009
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 4.84 million

Prior period

−USD 15.12 million

2024-01-01 – 2024-12-31
Current period

−USD 19.95 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-19951000 − -15115000 = -4836000 USD

-15115000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-19951000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Year-over-year change in Net income: -4836000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -19951000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1190306 Filing: 000127473726000009 Input fundies:NetIncome: -15115000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1191067 Filing: 000127473726000009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 346,000

Prior period

−USD 13.28 million

2024-01-01 – 2024-12-31
Current period

−USD 13.63 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13625000 − -13279000 = -346000 USD

-13279000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13625000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Year-over-year change in Operating cash flow: -346000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13625000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1215406 Filing: 000127473726000009 Input fundies:OperatingCashFlow: -13279000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1216052 Filing: 000127473726000009
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+24.5%

Prior period

USD 515,000

2024-01-01 – 2024-12-31
Current period

USD 641,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

641000 − 515000 = 126000 USD

515000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
641000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Year-over-year change in Capital expenditure: 126000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 641000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1217506 Filing: 000127473726000009 Input fundies:CapitalExpenditure: 515000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1218059 Filing: 000127473726000009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 66.58 million 100% of revenue
Cost of revenue USD 27.78 million 42% of revenue
Operating expenses USD 52.87 million 79% of revenue
Operating income −USD 14.07 million −21% of revenue
Tax, interest and other Derived USD 5.88 million 8.8% of revenue
Net income −USD 19.95 million −30% of revenue

Cash

Operating cash flow −USD 13.63 million −20% of revenue
Capital expenditure USD 641,000 1% of revenue
Free cash flow Derived −USD 14.27 million −21% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 115% of revenue.
2019 Operating loss: operating costs were 123% of revenue.
2020 Operating loss: operating costs were 136% of revenue.
2021 Operating loss: operating costs were 150% of revenue.
2022 Operating loss: operating costs were 201% of revenue.
2023 Operating loss: operating costs were 143% of revenue.
2024 Operating loss: operating costs were 125% of revenue.
2025 Operating loss: operating costs were 121% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	32440000	37320000 Derived	-4880000	3132000 Derived	-8012000	-9500000 Derived	Source 2018-01-01 – 2018-12-31: 32440000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -4880000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -8012000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -9301000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 199000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	40387000	49686000 Derived	-9299000	2739000 Derived	-12038000	-10114000 Derived	Source 2019-01-01 – 2019-12-31: 40387000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -9299000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -12038000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -9711000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 403000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	41975000	57160000 Derived	-15185000	1502000 Derived	-16687000	-14539000 Derived	Source 2020-01-01 – 2020-12-31: 41975000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -15185000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -16687000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -14084000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 455000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	48299000	72366000 Derived	-24067000	2784000 Derived	-26851000	-22639000 Derived	Source 2021-01-01 – 2021-12-31: 48299000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -24067000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -26851000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -20269000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 2370000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	45563000	91614000 Derived	-46051000	1336000 Derived	-47387000	-36462000 Derived	Source 2022-01-01 – 2022-12-31: 45563000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -46051000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -47387000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -32144000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 4318000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	52548000	75385000 Derived	-22837000	852000 Derived	-23689000	-15290000 Derived	Source 2023-01-01 – 2023-12-31: 52548000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -22837000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -23689000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -14462000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 828000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	55641000	69277000 Derived	-13636000	1479000 Derived	-15115000	-13794000 Derived	Source 2024-01-01 – 2024-12-31: 55641000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -13636000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -15115000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -13279000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 515000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	66575000	80645000 Derived	-14070000	5881000 Derived	-19951000	-14266000 Derived	Source 2025-01-01 – 2025-12-31: 66575000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -14070000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -19951000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -13625000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 641000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 66.6M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	32440000	Revenue: 32440000 Open source
20192019-12-31	Revenue	40387000	Revenue: 40387000 Open source
20202020-12-31	Revenue	41975000	Revenue: 41975000 Open source
20212021-12-31	Revenue	48299000	Revenue: 48299000 Open source
20222022-12-31	Revenue	45563000	Revenue: 45563000 Open source
20232023-12-31	Revenue	52548000	Revenue: 52548000 Open source
20242024-12-31	Revenue	55641000	Revenue: 55641000 Open source
20252025-12-31	Revenue	66575000	Revenue: 66575000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 32440000 Open source
20192019-12-31	Year over year	24.5%	Revenue: 40387000 Open source Revenue: 32440000 Open source
20202020-12-31	Year over year	3.9%	Revenue: 41975000 Open source Revenue: 40387000 Open source
20212021-12-31	Year over year	15.1%	Revenue: 48299000 Open source Revenue: 41975000 Open source
20222022-12-31	Year over year	-5.7%	Revenue: 45563000 Open source Revenue: 48299000 Open source
20232023-12-31	Year over year	15.3%	Revenue: 52548000 Open source Revenue: 45563000 Open source
20242024-12-31	Year over year	5.9%	Revenue: 55641000 Open source Revenue: 52548000 Open source
20252025-12-31	Year over year	19.7%	Revenue: 66575000 Open source Revenue: 55641000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -21.1% 2025

Net margin -30% 2025

Free cash flow margin -21.4% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	-15%	Operating Income: -4880000 Open source Revenue: 32440000 Open source
20192019-12-31	Operating margin	-23%	Operating Income: -9299000 Open source Revenue: 40387000 Open source
20202020-12-31	Operating margin	-36.2%	Operating Income: -15185000 Open source Revenue: 41975000 Open source
20212021-12-31	Operating margin	-49.8%	Operating Income: -24067000 Open source Revenue: 48299000 Open source
20222022-12-31	Operating margin	-101.1%	Operating Income: -46051000 Open source Revenue: 45563000 Open source
20232023-12-31	Operating margin	-43.5%	Operating Income: -22837000 Open source Revenue: 52548000 Open source
20242024-12-31	Operating margin	-24.5%	Operating Income: -13636000 Open source Revenue: 55641000 Open source
20252025-12-31	Operating margin	-21.1%	Operating Income: -14070000 Open source Revenue: 66575000 Open source
20182018-12-31	Net margin	-24.7%	Net Income: -8012000 Open source Revenue: 32440000 Open source
20192019-12-31	Net margin	-29.8%	Net Income: -12038000 Open source Revenue: 40387000 Open source
20202020-12-31	Net margin	-39.8%	Net Income: -16687000 Open source Revenue: 41975000 Open source
20212021-12-31	Net margin	-55.6%	Net Income: -26851000 Open source Revenue: 48299000 Open source
20222022-12-31	Net margin	-104%	Net Income: -47387000 Open source Revenue: 45563000 Open source
20232023-12-31	Net margin	-45.1%	Net Income: -23689000 Open source Revenue: 52548000 Open source
20242024-12-31	Net margin	-27.2%	Net Income: -15115000 Open source Revenue: 55641000 Open source
20252025-12-31	Net margin	-30%	Net Income: -19951000 Open source Revenue: 66575000 Open source
20182018-12-31	Free cash flow margin	-29.3%	Revenue: 32440000 Open source Operating Cash Flow: -9301000 Open source Capital Expenditure: 199000 Open source
20192019-12-31	Free cash flow margin	-25%	Revenue: 40387000 Open source Operating Cash Flow: -9711000 Open source Capital Expenditure: 403000 Open source
20202020-12-31	Free cash flow margin	-34.6%	Revenue: 41975000 Open source Operating Cash Flow: -14084000 Open source Capital Expenditure: 455000 Open source
20212021-12-31	Free cash flow margin	-46.9%	Revenue: 48299000 Open source Operating Cash Flow: -20269000 Open source Capital Expenditure: 2370000 Open source
20222022-12-31	Free cash flow margin	-80%	Revenue: 45563000 Open source Operating Cash Flow: -32144000 Open source Capital Expenditure: 4318000 Open source
20232023-12-31	Free cash flow margin	-29.1%	Revenue: 52548000 Open source Operating Cash Flow: -14462000 Open source Capital Expenditure: 828000 Open source
20242024-12-31	Free cash flow margin	-24.8%	Revenue: 55641000 Open source Operating Cash Flow: -13279000 Open source Capital Expenditure: 515000 Open source
20252025-12-31	Free cash flow margin	-21.4%	Revenue: 66575000 Open source Operating Cash Flow: -13625000 Open source Capital Expenditure: 641000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	-9301000	Operating Cash Flow: -9301000 Open source
20192019-12-31	Operating cash flow	-9711000	Operating Cash Flow: -9711000 Open source
20202020-12-31	Operating cash flow	-14084000	Operating Cash Flow: -14084000 Open source
20212021-12-31	Operating cash flow	-20269000	Operating Cash Flow: -20269000 Open source
20222022-12-31	Operating cash flow	-32144000	Operating Cash Flow: -32144000 Open source
20232023-12-31	Operating cash flow	-14462000	Operating Cash Flow: -14462000 Open source
20242024-12-31	Operating cash flow	-13279000	Operating Cash Flow: -13279000 Open source
20252025-12-31	Operating cash flow	-13625000	Operating Cash Flow: -13625000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.3M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	-9500000	Operating Cash Flow: -9301000 Open source Capital Expenditure: 199000 Open source
20192019-12-31	Free cash flow	-10114000	Operating Cash Flow: -9711000 Open source Capital Expenditure: 403000 Open source
20202020-12-31	Free cash flow	-14539000	Operating Cash Flow: -14084000 Open source Capital Expenditure: 455000 Open source
20212021-12-31	Free cash flow	-22639000	Operating Cash Flow: -20269000 Open source Capital Expenditure: 2370000 Open source
20222022-12-31	Free cash flow	-36462000	Operating Cash Flow: -32144000 Open source Capital Expenditure: 4318000 Open source
20232023-12-31	Free cash flow	-15290000	Operating Cash Flow: -14462000 Open source Capital Expenditure: 828000 Open source
20242024-12-31	Free cash flow	-13794000	Operating Cash Flow: -13279000 Open source Capital Expenditure: 515000 Open source
20252025-12-31	Free cash flow	-14266000	Operating Cash Flow: -13625000 Open source Capital Expenditure: 641000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

69.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Liabilities / assets	123.3%	Total Liabilities: 35621000 Open source Total Assets: 28887000 Open source
20192019-12-31	Liabilities / assets	37%	Total Liabilities: 32651000 Open source Total Assets: 88310000 Open source
20202020-12-31	Liabilities / assets	46.6%	Total Liabilities: 36536000 Open source Total Assets: 78375000 Open source
20212021-12-31	Liabilities / assets	31.2%	Total Liabilities: 38509000 Open source Total Assets: 123445000 Open source
20222022-12-31	Liabilities / assets	50.8%	Total Liabilities: 43761000 Open source Total Assets: 86221000 Open source
20232023-12-31	Liabilities / assets	60.1%	Total Liabilities: 34250000 Open source Total Assets: 56944000 Open source
20242024-12-31	Liabilities / assets	78.7%	Total Liabilities: 35149000 Open source Total Assets: 44689000 Open source
20252025-12-31	Liabilities / assets	69.9%	Total Liabilities: 40573000 Open source Total Assets: 58022000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.45× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Current assets / current liabilities	2.38×	Current Assets: 21312000 Open source Current Liabilities: 8952000 Open source
20192019-12-31	Current assets / current liabilities	13.78×	Current Assets: 81250000 Open source Current Liabilities: 5895000 Open source
20202020-12-31	Current assets / current liabilities	8.04×	Current Assets: 70517000 Open source Current Liabilities: 8771000 Open source
20212021-12-31	Current assets / current liabilities	12.1×	Current Assets: 112734000 Open source Current Liabilities: 9318000 Open source
20222022-12-31	Current assets / current liabilities	7.55×	Current Assets: 72611000 Open source Current Liabilities: 9623000 Open source
20232023-12-31	Current assets / current liabilities	4.02×	Current Assets: 47841000 Open source Current Liabilities: 11902000 Open source
20242024-12-31	Current assets / current liabilities	2.7×	Current Assets: 36455000 Open source Current Liabilities: 13506000 Open source
20252025-12-31	Current assets / current liabilities	3.45×	Current Assets: 48893000 Open source Current Liabilities: 14159000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 8.01 million Exact value Exact value: -8012000 USD 2018-01-01 – 2018-12-31: -8012000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2018-12-31 EXAGEN INC. (edgar:1274737) Net Income: -8012000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8012000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/exdx-20191231.htm#1502939 Filing: 000127473720000026 The citation records this snapshot. The page link may show a newer release later.	−USD 9.3 million Exact value Exact value: -9301000 USD 2018-01-01 – 2018-12-31: -9301000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2018-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -9301000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9301000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/exdx-20191231.htm#1544644 Filing: 000127473720000026 The citation records this snapshot. The page link may show a newer release later.	USD 199,000 Exact value Exact value: 199000 USD 2018-01-01 – 2018-12-31: 199000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2018-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 199000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 199000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/exdx-20191231.htm#1548738 Filing: 000127473720000026 The citation records this snapshot. The page link may show a newer release later.	−USD 9.5 million Calculation and evidence -9301000 − 199000 USD Exact free cash flow: -9500000 USD 2018-01-01 – 2018-12-31: -9301000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 199000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2018-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -9500000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9301000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/exdx-20191231.htm#1544644 Filing: 000127473720000026 Input fundies:CapitalExpenditure: 199000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/exdx-20191231.htm#1548738 Filing: 000127473720000026 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 12.04 million Exact value Exact value: -12038000 USD 2019-01-01 – 2019-12-31: -12038000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2019-12-31 EXAGEN INC. (edgar:1274737) Net Income: -12038000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12038000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000015/exdx-20201231.htm#1280092 Filing: 000127473721000015 The citation records this snapshot. The page link may show a newer release later.	−USD 9.71 million Exact value Exact value: -9711000 USD 2019-01-01 – 2019-12-31: -9711000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2019-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -9711000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9711000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000015/exdx-20201231.htm#1312379 Filing: 000127473721000015 The citation records this snapshot. The page link may show a newer release later.	USD 403,000 Exact value Exact value: 403000 USD 2019-01-01 – 2019-12-31: 403000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2019-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 403000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 403000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000015/exdx-20201231.htm#1315461 Filing: 000127473721000015 The citation records this snapshot. The page link may show a newer release later.	−USD 10.11 million Calculation and evidence -9711000 − 403000 USD Exact free cash flow: -10114000 USD 2019-01-01 – 2019-12-31: -9711000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 403000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2019-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -10114000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9711000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000015/exdx-20201231.htm#1312379 Filing: 000127473721000015 Input fundies:CapitalExpenditure: 403000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473721000015/exdx-20201231.htm#1315461 Filing: 000127473721000015 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 16.69 million Exact value Exact value: -16687000 USD 2020-01-01 – 2020-12-31: -16687000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2020-12-31 EXAGEN INC. (edgar:1274737) Net Income: -16687000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16687000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000162828022006926/exdx-20211231.htm#1125945 Filing: 000162828022006926 The citation records this snapshot. The page link may show a newer release later.	−USD 14.08 million Exact value Exact value: -14084000 USD 2020-01-01 – 2020-12-31: -14084000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2020-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -14084000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14084000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000162828022006926/exdx-20211231.htm#1154443 Filing: 000162828022006926 The citation records this snapshot. The page link may show a newer release later.	USD 455,000 Exact value Exact value: 455000 USD 2020-01-01 – 2020-12-31: 455000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2020-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 455000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 455000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000162828022006926/exdx-20211231.htm#1157569 Filing: 000162828022006926 The citation records this snapshot. The page link may show a newer release later.	−USD 14.54 million Calculation and evidence -14084000 − 455000 USD Exact free cash flow: -14539000 USD 2020-01-01 – 2020-12-31: -14084000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 455000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2020-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -14539000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14084000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000162828022006926/exdx-20211231.htm#1154443 Filing: 000162828022006926 Input fundies:CapitalExpenditure: 455000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000162828022006926/exdx-20211231.htm#1157569 Filing: 000162828022006926 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 26.85 million Exact value Exact value: -26851000 USD 2021-01-01 – 2021-12-31: -26851000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2021-12-31 EXAGEN INC. (edgar:1274737) Net Income: -26851000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26851000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000019/exdx-20221231.htm#1175175 Filing: 000127473723000019 The citation records this snapshot. The page link may show a newer release later.	−USD 20.27 million Exact value Exact value: -20269000 USD 2021-01-01 – 2021-12-31: -20269000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2021-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -20269000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20269000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000019/exdx-20221231.htm#1200656 Filing: 000127473723000019 The citation records this snapshot. The page link may show a newer release later.	USD 2.37 million Exact value Exact value: 2370000 USD 2021-01-01 – 2021-12-31: 2370000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2021-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 2370000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2370000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000019/exdx-20221231.htm#1202772 Filing: 000127473723000019 The citation records this snapshot. The page link may show a newer release later.	−USD 22.64 million Calculation and evidence -20269000 − 2370000 USD Exact free cash flow: -22639000 USD 2021-01-01 – 2021-12-31: -20269000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 2370000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2021-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -22639000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20269000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000019/exdx-20221231.htm#1200656 Filing: 000127473723000019 Input fundies:CapitalExpenditure: 2370000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473723000019/exdx-20221231.htm#1202772 Filing: 000127473723000019 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 47.39 million Exact value Exact value: -47387000 USD 2022-01-01 – 2022-12-31: -47387000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2022-12-31 EXAGEN INC. (edgar:1274737) Net Income: -47387000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47387000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/exdx-20231231.htm#1140480 Filing: 000127473724000022 The citation records this snapshot. The page link may show a newer release later.	−USD 32.14 million Exact value Exact value: -32144000 USD 2022-01-01 – 2022-12-31: -32144000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2022-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -32144000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -32144000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/exdx-20231231.htm#1166953 Filing: 000127473724000022 The citation records this snapshot. The page link may show a newer release later.	USD 4.32 million Exact value Exact value: 4318000 USD 2022-01-01 – 2022-12-31: 4318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2022-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 4318000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4318000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/exdx-20231231.htm#1168960 Filing: 000127473724000022 The citation records this snapshot. The page link may show a newer release later.	−USD 36.46 million Calculation and evidence -32144000 − 4318000 USD Exact free cash flow: -36462000 USD 2022-01-01 – 2022-12-31: -32144000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 4318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2022-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -36462000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32144000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/exdx-20231231.htm#1166953 Filing: 000127473724000022 Input fundies:CapitalExpenditure: 4318000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473724000022/exdx-20231231.htm#1168960 Filing: 000127473724000022 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 23.69 million Exact value Exact value: -23689000 USD 2023-01-01 – 2023-12-31: -23689000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2023-12-31 EXAGEN INC. (edgar:1274737) Net Income: -23689000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23689000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000019/exdx-20241231.htm#1154899 Filing: 000127473725000019 The citation records this snapshot. The page link may show a newer release later.	−USD 14.46 million Exact value Exact value: -14462000 USD 2023-01-01 – 2023-12-31: -14462000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2023-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -14462000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14462000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000019/exdx-20241231.htm#1176619 Filing: 000127473725000019 The citation records this snapshot. The page link may show a newer release later.	USD 828,000 Exact value Exact value: 828000 USD 2023-01-01 – 2023-12-31: 828000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2023-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 828000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 828000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000019/exdx-20241231.htm#1178626 Filing: 000127473725000019 The citation records this snapshot. The page link may show a newer release later.	−USD 15.29 million Calculation and evidence -14462000 − 828000 USD Exact free cash flow: -15290000 USD 2023-01-01 – 2023-12-31: -14462000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 828000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2023-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -15290000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14462000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000019/exdx-20241231.htm#1176619 Filing: 000127473725000019 Input fundies:CapitalExpenditure: 828000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473725000019/exdx-20241231.htm#1178626 Filing: 000127473725000019 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 15.12 million Exact value Exact value: -15115000 USD 2024-01-01 – 2024-12-31: -15115000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2024-12-31 EXAGEN INC. (edgar:1274737) Net Income: -15115000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15115000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1191067 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	−USD 13.28 million Exact value Exact value: -13279000 USD 2024-01-01 – 2024-12-31: -13279000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2024-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -13279000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13279000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1216052 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	USD 515,000 Exact value Exact value: 515000 USD 2024-01-01 – 2024-12-31: 515000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2024-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 515000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 515000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1218059 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	−USD 13.79 million Calculation and evidence -13279000 − 515000 USD Exact free cash flow: -13794000 USD 2024-01-01 – 2024-12-31: -13279000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 515000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2024-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -13794000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13279000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1216052 Filing: 000127473726000009 Input fundies:CapitalExpenditure: 515000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1218059 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 19.95 million Exact value Exact value: -19951000 USD 2025-01-01 – 2025-12-31: -19951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Net Income: -19951000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19951000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1190306 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	−USD 13.63 million Exact value Exact value: -13625000 USD 2025-01-01 – 2025-12-31: -13625000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Operating Cash Flow: -13625000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13625000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1215406 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	USD 641,000 Exact value Exact value: 641000 USD 2025-01-01 – 2025-12-31: 641000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Capital Expenditure: 641000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 641000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1217506 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.	−USD 14.27 million Calculation and evidence -13625000 − 641000 USD Exact free cash flow: -14266000 USD 2025-01-01 – 2025-12-31: -13625000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 641000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EXAGEN INC. · 2025-12-31 EXAGEN INC. (edgar:1274737) Free cash flow: -14266000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T17:57:26Z Snapshot: 7983b1aac87c1a3744154ee45590815fc7a53b4b1b285223e53f65f6ad358e0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1274737?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13625000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1215406 Filing: 000127473726000009 Input fundies:CapitalExpenditure: 641000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1274737/000127473726000009/exdx-20251231.htm#1217506 Filing: 000127473726000009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 2,436 latest values · 2,436 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001274737, 1274737, XGN, edgar:1274737

Also known as EXAGEN DIAGNOSTICS INC, EXAGEN INC.

EXAGEN INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation